Table 3 |
||||||||
|
Impact of BMI on OA related quality of life |
||||||||
| BMI |
||||||||
|
|
||||||||
| =<24.9 |
P* |
25–29.9 |
p* |
>= 30 |
||||
|
|
||||||||
| AIMS2-SF scales |
Mean |
SD |
SD |
Mean |
Mean |
SD |
||
|
|
||||||||
| Lower body |
2.46 |
1.97 |
0.409 |
2.59 |
2.014 |
<0.001 |
3.31 |
1.89 |
| Upper body |
1.47 |
2.35 |
0.637 |
1.56 |
2.43 |
0.553 |
1.46 |
2.02 |
| Symptom |
4.55 |
2.25 |
0.158 |
4.80 |
2.15 |
0.029 |
5.31 |
2.17 |
| Affect |
2.66 |
1.31 |
0.073 |
2.85 |
1.27 |
<0.001 |
3.22 |
1.42 |
| Social |
4.49 |
1.83 |
0.173 |
4.68 |
1.80 |
0.173 |
4.87 |
1.86 |
| PHQ-9 sum score |
14.32 |
4.59 |
0.165 |
14.85 |
4.44 |
0.002 |
16.67 |
4.93 |
|
|
||||||||
|
* by means of ANCOVA, adjusted for age, disease duration, Kellgren and Lawrence-score and number of comorbidities for comparing normal vs. overweight and overweight vs. obese |
||||||||
|
Rosemann et al. International Journal of Behavioral Nutrition and Physical Activity 2008 5:4 doi:10.1186/1479-5868-5-4 |
||||||||